Skip to main content
. 2018 Mar 12;9(5):548–554. doi: 10.1111/1759-7714.12611

Table 1.

Patient and tumor characteristics

No Age/ Gender Stage Pathology Interval (months) Location Size (mm) Power/Time (W/min) Local recurrence (months) Comorbidity Follow‐up (months/ status)
1 61/M IIa ADC 18 Right inferior 27 60/6 None None 38/survived
2 70/F Ib SQ 63 Left superior 42 70/8 13 Chronic bronchitis 17/died
3 46/F Ib SQ 23 Left superior 28 60/7 None Diabetes (type I) 16/survived
4 55/M IIa ADC 15 Right middle 25 60/6 26 None 32/died
5 62/F Ib ADC 12 Right superior 33 70/8 None Hypertension 26/survived
6 54/M IIa SQ 18 Right inferior 18 60/5 None None 37/survived
7 64/M Ib ADC 9 Left superior 44 70/8 None Chronic bronchitis 23/survived
8 59/M IIIa ADC 11 Left inferior 30 60/8 9 Diabetes (type II) 11/died
9 71/M Ia SQ 37 Right inferior 20 60/6 None Ischemic heart disease 10/survived
10 68/M IIIa ADC 14 Left inferior 13 60/4 None Ischemic heart disease 6/survived
11 53/M Ia Sarcoma 46 Left superior 52 70/8, 60/6 & 16 Diabetes (type II) 20/ died

Stage: initial diagnosis. Interval: period between the date of the initial procedure and before microwave ablation (MWA). ADC, adenocarcinoma; SQ, squamous cell carcinoma.